Reactive capillary endothelial proliferation: Which Medications Cause It? (45 Reports Across 13 Drugs)
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Reactive capillary endothelial proliferation has been reported as an adverse event with 13 different drugs in the FDA's FAERS database, with 45 total reports. 12 of these reports resulted in death.The drugs most commonly associated with Reactive capillary endothelial proliferation are CAMRELIZUMAB, CAPECITABINE, and CISPLATIN.
45
Total Reports
13
Drugs Involved
12
Deaths
6
Hospitalizations
57.2 yrs
Average Patient Age
9.7% / 90.3%
Female / Male
Which Drugs Cause Reactive capillary endothelial proliferation Most Often?
| Drug | Reports | % of Drug Reports | Deaths | Hosp. | Life-Threat. |
|---|---|---|---|---|---|
| CAMRELIZUMAB | 41 | 9.6% | 12 | 5 | 1 |
| CAPECITABINE | 19 | 0.0% | 8 | 1 | 1 |
| CISPLATIN | 19 | 0.0% | 10 | 2 | 1 |
| DOCETAXEL\DOCETAXEL ANHYDROUS | 17 | 0.4% | 9 | 1 | 1 |
| OXALIPLATIN | 11 | 0.0% | 2 | 2 | 0 |
| ATEZOLIZUMAB | 10 | 0.0% | 1 | 0 | 0 |
| BEVACIZUMAB | 10 | 0.0% | 0 | 0 | 0 |
| PEMBROLIZUMAB | 7 | 0.0% | 1 | 0 | 0 |
| SINTILIMAB | 7 | 1.1% | 1 | 0 | 0 |
| TORIPALIMAB | 6 | 0.5% | 1 | 0 | 0 |
| LENVATINIB | 5 | 0.0% | 0 | 0 | 0 |
| SORAFENIB | 5 | 0.1% | 0 | 0 | 0 |
| TISLELIZUMAB | 5 | 0.1% | 1 | 0 | 0 |